Skip to content
PL
Toggle navigation
About Selvita
Management
Supervisory Board
Scientific Advisory Board
Awards and recognitions
CSR
For the media
Contact
Services
Computational Chemistry
Target identification and ligandability assessment
High-Throughput Screening (HTS) library design
Analysis of screening data
Multi-objective lead optimization
Medicinal chemistry
Synthesis of chemical series and libraries
Fully integrated drug discovery projects
Hit-to-lead and lead optimization
Process Research
Feasibility studies / Route scouting & development
Process optimization, parametrization & scale up
Laboratory scale custom synthesis of APIs and NCEs
Technology transfer
Preclinical Research
ADME
Toxicology studies in vitro
DMPK
Pharmacodynamics
Assay development services
Protein Chemistry
Customized recombinant protein production
Biochemical and biophysical analyses of proteins
Structural analysis of proteins
Analysis of protein-protein/-ligand interaction
Comparative studies of biosimilar drugs
Non-clinical in vitro pharmacodynamic studies
Process and product related impurities
Physicochemical and structural properties characterization
Non-clinical in vitro proliferation studies
Analytical chemistry
Analytical services for agrochemical and chemical industry
Analytical services for pharma
Physicochemical analysis of chemical substances
ADME/DMPK services
Industrial chemistry
Integrated Drug Discovery Projects
Medicinal chemistry
In silico
Biology
ADME
Quality assurance
Bioinformatics
Research and Development
Pipeline
Targeted Therapies Platform
SEL24
SEL120
Cancer Metabolism and Immunometabolism Platform
Immunology Platform
Immuno-Oncology Platform
Download a poster
Careers
Current job offers
Benefits
Recruitment process
How to prepare for an interview
Your career at Selvita Group
Meet Selvita
Meet the city
Investor relations
Stock market reports
Reports and presentations
Financial results
Investor calendar
Stock information
Shareholder structure
Contact for investors
News
News and Events
Media about us
Contact
PL
Kalendarium
Selvita
Investor relations
Investor calendar
Stock information
Stock market reports
Investor calendar
Shareholder structure
Financial results
Reports and presentations
Contact for investors
Upcoming
Consolidated quarterly Q3 2018 report publication
Date:
14.11.2018
Past
Consolidated half year H1 2018 report publication
Date:
29.08.2018
Consolidated quarterly Q1 2018 report publication
Date:
22.05.2018
Annual report 2017 publication
Date:
27.03.2018
Selvita presents at Biotech Showcase
Date:
01.01.2017
Consolidated quarterly Q3 2017 report publication
Date:
16.11.2017
Consolidated half year H1 2017 report publication
Date:
14.09.2017
Consolidated quarterly Q1 2017 report publication
Date:
30.05.2017
Annual Report 2016 publication
Date:
19.04.2017
Selvita presents at Biotech and Money Inv€$tival Showcase – 18 Nov 2016
Date:
30.09.2016
Q3 2016 report publication date
Date:
09.11.2016
H1 2016 report publication date
Date:
30.08.2016
Consolidated quarterly Q1 2016 report publication
Date:
12.05.2016
Annual Report 2015 publication
Date:
21.03.2016
Consolidated quarterly Q3 2015 report publication
Date:
05.11.2015
Consolidated half year H1 2015 report publication
Date:
13.08.2015
Consolidated quarterly Q1 2015 report publication
Date:
12.05.2015
Annual Report 2014 publication date
Date:
19.03.2015
Consolidated quarterly Q3 2014 report publication date
Date:
06.11.2014
Consolidated quarterly report Q2 2014 publication date
Date:
07.08.2014
Consolidated quarterly report Q1 2014 publication date
Date:
13.05.2014
Consolidated quarterly report Q4 2013 publication date
Date:
14.02.2014
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept
More